A Single-blind RCT to Investigate the Effect of a Novel Herbal Patch for

Status Recruiting

Clinical Trial Summary

Disorders and injuries of tendons and ligaments are some of the most diagnosed musculoskeletal (MS) disorders clinically. Nearly half of the 33 million MS disorders reported in the United States each year are tendon and ligament injuries. Although most of such injuries are non-fatal, they are severely debilitating, resulting in significant reduction in patient's quality of life, loss of productivity, and considerable costs to the healthcare system. Among all tendon and ligament disorders and injuries, tendon and ligament overuse disorders are the most common and incapacitating ones. Tendinopathy is a painful tendon overuse disorder, which increases with population aging. It has been estimated that about 30% of consultations for MS complaints in a general practice were related to tendinopathy. The affected tendon is presented with local tenderness, swelling and pain, causing physical disability of the affected individual. The affected tendon degenerates and finally ruptures. Common sites of tendinopathy include supraspinatus, common wrist extensor, flexor tendon, patellar tendon, and Achilles tendon. The outcomes of both conservative treatments and surgeries are not satisfactory, with recurrent pain and tendon retear after surgery. Plantar fasciitis is a chronic painful, degenerative condition of the plantar fascia. It is caused by repetitive traumas at its origin on the calcaneus. Plantar fascia is a thick, ribbon-like fibrous ligament that connects the medial calcaneal tubercle to the heads of the metatarsal bones. It contributes to the support of the foot arch by acting as a tie-rod, where it undergoes tension when the foot bears weight. Therefore, although plantar fascia is anatomically defined as a ligament, it functions similar to a tendon. This study aims to conduct a randomized controlled study to test the efficacy of CDAM patch for the treatment of plantar fasciitis in patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05584046
Study type	Interventional
Source	Chinese University of Hong Kong
Contact	Patrick Shu-hang YUNG
Phone	+852 3505 2728
Email	patrickyung@cuhk.edu.hk
Status	Recruiting
Phase	N/A
Start date	September 20, 2023
Completion date	June 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02546115` - RCT - Assessing the Benefits of the Use of a Tension Night Splint in Patients With Plantar Fasciitis	N/A
Unknown status	`NCT01882894` - Efficacy of a Custom Temporary Foot Orthosis for Plantar Fasciitis Treatment	N/A
Terminated	`NCT01996111` - Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis	N/A
Completed	`NCT01659827` - Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis	N/A
Completed	`NCT00888394` - Effectiveness of Podiatry on Plantar Pain	Phase 4
Completed	`NCT00758641` - Platelet Rich Plasma to Treat Plantar Fasciitis	Phase 4
Terminated	`NCT00527748` - Foot and Ankle Range of Motion (Stretching) Apparatus	N/A
Completed	`NCT04088383` - Amnios™ RT Outcomes Study	N/A
Completed	`NCT01994759` - Optimal Treatment of Plantar Fasciitis: Physical Training, Glucocorticoid Injections or a Combination Thereof.	Phase 4
Completed	`NCT02646579` - Effects of Dry Needling Using Spinal and Peripheral Sites Versus Peripheral Sites Only	N/A
Completed	`NCT05592808` - Comparison of Taping Techniques in Plantar Fasciitis	N/A
Not yet recruiting	`NCT04125264` - Intense Therapeutic Ultrasound (ITU) to Treat Plantar Fasciitis	N/A
Completed	`NCT02546089` - ABI v Dry Needling for Plantar Fasciitis	N/A
Completed	`NCT00765843` - A Trial of Custom Foot Orthoses for the Treatment of Plantar Heel Pain	N/A
Completed	`NCT00155324` - Change and Clinical Significance of Plantar Fascia Thickness After ESWT	N/A
Completed	`NCT04941469` - Effectiveness of Specifically Optimized Off-the-counter Foot Orthosis for the Subtle Cavus Foot	N/A
Completed	`NCT06055933` - Effect of Kinesio Taping and Extracorporeal Shock Wave Therapy on Plantar Fasciitis
Recruiting	`NCT02539082` - the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis	Phase 4
Enrolling by invitation	`NCT01786057` - Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis	Phase 2/Phase 3
Recruiting	`NCT03978234` - Evaluating the Safety and Effect of abobotulinumtoxinA in the Gastrocnemius Muscle to Improve Equinus and Plantar Fasciitis Pain	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Single-blind RCT to Investigate the Effect of a Novel Herbal Patch for the Treatment of PF

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms